This combination is designed to manage chronic respiratory airway conditions, helping to alleviate inflammation and bronchodilation for improved lung function and respiratory comfort.
This combination is designed to manage chronic respiratory airway conditions, helping to alleviate inflammation and bronchodilation for improved lung function and respiratory comfort.
Mechanism of Action
Fluticasone acts as an anti-inflammatory corticosteroid to reduce airway swelling, while salmeterol acts as a long-acting beta-2 agonist to relax bronchial muscles. Together, they provide sustained airway patency for patients with long-term breathing management needs.
Route of Administration
Inhalation
Onset Time
15-30 minutes
Duration
12 hours
Contraindications
Acute asthma attacks, Severe milk protein allergy
Severe Adverse Events
Increased pneumonia risk, Adrenal suppression, Bone density reduction
Common Side Effects
Throat irritation, Hoarseness, Dry mouth
Uncommon Side Effects
Tremor, Headache, Palpitations
Drug Interactions
Ketoconazole, Ritonavir, Beta-blockers
Pregnancy Safety Warnings
Use only if the potential benefit outweighs the risk to the fetus.
Information related to Fluticasone with Salmeterol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
